The impact of cannabis use on patient outcomes post immune checkpoint inhibitor (ICI) therapy in a longitudinal observational trial: The DiRECT Cohort.

Authors

• S. Yao, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• C.-S. Li, University of Rochester Medical Center, Rochester, NY
• U. Gada, University of Rochester Medical Center, Rochester, NY
• D. Smith, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• A.A. Case, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• L.J. Peppone, University of Rochester Medical Center, Rochester, NY
• A.N. Freedman, National Cancer Institute, Rockville, MD
• K.K. Filipski, National Cancer Institute, Bethesda, MD
• M.R. Mohamed, University of Rochester, Rochester, NY
• A.V. Chua, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• H. Sun, University of Rochester Medical Center, Rochester, NY
• L. Sakoda, Kaiser Permanente Northern California, Pleasanton, CA
• G.H. Cantuaria, Northside Hospital, Atlanta, GA
• J.M. Suga, Kaiser Permanente, Vallejo, CA
• Augusto Ochoa, LSU Health Sciences Center - New OrleansFollow
• I. Puzanov, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• K.M. Mustian, University of Rochester Medical Center, Rochester, NY
• C.B. Ambrosone, Roswell Park Comprehensive Cancer Center, Buffalo, NY
• G.R. Morrow, University of Rochester Medical Center, Rochester, NY
• C.S. Kamen, University of Rochester Medical Center, Rochester, NY

Document Type

Conference Proceeding

Publication Date

5-28-2025

Publication Title

Journal of Clinical Oncology

Abstract

2025 ASCO Annual Meeting, May 30-June 3, Chicago, IL

Volume

43

Issue

16_suppl

Comments

Abstract #12081

Rights

© 2025, Wolters Kluwer Health

Recommended Citation

Yao, S.; Li, C.-S.; Gada, U.; Smith, D.; Case, A.A.; Peppone, L.J.; Freedman, A.N.; Filipski, K.K.; Mohamed, M.R.; Chua, A.V.; Sun, H.; Sakoda, L.; Cantuaria, G.H.; Suga, J.M.; Ochoa, Augusto; Puzanov, I.; Mustian, K.M.; Ambrosone, C.B.; Morrow, G.R.; and Kamen, C.S., "The impact of cannabis use on patient outcomes post immune checkpoint inhibitor (ICI) therapy in a longitudinal observational trial: The DiRECT Cohort." (2025). School of Medicine Faculty Publications. 5184.
https://digitalscholar.lsuhsc.edu/som_facpubs/5184
10.1200/JCO.2025.43.16_suppl.12081